Also recent data showing low-frequency del(17p) sub clones (<25% of CLL cells) in the absence of a TP53 mutation has been demonstrated to mirror that of cases with no del(17p) in the chemoimmunotherapy setting (12, 19). The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.